MYRIAD MEDICAL

What MYRIAD MEDICAL does

Myriad Medical, LLC is a privately held medical device company headquartered in Tampa, Florida (operating under the DBA "Myriad Oncology") that develops and commercializes the Prostate Caddy™, a patented single-use endorectal balloon used to immobilize the prostate during external beam radiation therapy for prostate cancer. The device is built around a thermo-sensitive polymer with a patented longitudinally symmetric barrel-shaped design intended to reduce anatomical distortion of the prostate–rectum interface, maintain reproducible daily insertion depth (via depth markings and a 2-way locking stopper), and minimize rectal wall radiation exposure. Compatible with 3DCRT, IMRT, IGRT, SBRT, and Proton Therapy, the Prostate Caddy addresses intrafraction prostate motion and patient-tolerance limitations associated with traditional rounded rectal balloons.

The company sells Prostate Caddy directly to US healthcare providers — primarily hospitals with radiation oncology departments and standalone radiation therapy centers — through an enterprise field-sales motion supported by clinical educator in-service training prior to first use. Because the device is a disposable consumed at each treatment session, unit revenue is inherently recurring across patient courses at adopting centers. Marketing is content-driven, with parallel professional and patient blogs plus a clinical news section aimed at radiation oncologists, radiation therapists, and dosimetrists. In June 2019, Myriad Medical announced a strategic partnership with C4 Imaging to introduce the first positive signal LDR MRI marker for prostate brachytherapy, extending the company's footprint from external beam radiation therapy into the brachytherapy segment. No external funding rounds, headcount, or revenue figures are publicly disclosed, and operations are concentrated domestically.

Name

MYRIAD MEDICAL

Legal name

Myriad Medical, LLC

Website

https://myriadoncology.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Myriad Medical, LLC is a privately held Tampa, Florida medical device company that sells the Prostate Caddy, a patented single-use endorectal balloon for prostate immobilization during external beam radiation therapy, directly to US hospitals and radiation therapy centers.

Ownership category

akta.pro rank

Headquarters

HQ city

Tampa

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Prostate Caddy Device Sales: Myriad Medical generates revenue through the sale of Prostate Caddy endorectal balloon devices to healthcare providers. The device is used for each radiation treatment session and is discarded after use, suggesting recurring disposable purchases from treatment centers.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Myriad Medical manufactures and sells the Prostate Caddy™, a patented endorectal balloon device used during external beam radiation therapy for prostate cancer treatment. The device immobilizes the prostate using a longitudinally symmetric barrel-shaped design, enables reproducible daily treatment setup via depth markings and a locking stopper, and reduces rectal wall exposure to radiation. It is used with 3DCRT, IMRT, IGRT, SBRT, and Proton Therapy modalities and is sold as a disposable per-treatment device to hospitals and radiation therapy centers.

Product overview

MYRIAD MEDICAL offers the Prostate Caddy™ as its primary product, a prostate immobilization device (endorectal balloon) used during external beam radiation therapy for men with prostate cancer. The device immobilizes the prostate to enable precise and reproducible radiation delivery while minimizing radiation exposure to surrounding tissues, particularly the rectum. In 2019, MYRIAD MEDICAL partnered with C4 Imaging to introduce the First Positive Signal LDR MRI Marker, expanding their prostate cancer treatment portfolio to include brachytherapy markers.

Differentiator

Problem solved

Functional benefit

Brands

• Prostate Caddy: A prostate immobilization device (endorectal balloon) used during external beam radiation therapy for prostate cancer treatment. The device helps minimize prostate movement, maintain treatment consistency, and reduce rectal exposure during radiation therapy.

Products and services

• Prostate Caddy™ A patented endorectal balloon device for prostate immobilization during external beam radiation therapy for prostate cancer. Features a longitudinally symmetric barrel-shaped design that reduces anatomical distortion of the prostate interface, minimizes patient discomfort, and separates rectal mucosa from the treatment field. Used with 3DCRT, IMRT, IGRT, SBRT, and Proton Therapy. Sold as a disposable device to hospitals and radiation therapy centers.

Quantifiable outcome

• Reduced prostate intrafraction motion during external beam radiotherapy
• +3 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• C4 ImagingcoreStrategic or Co-development Partner · 13 June 2019Myriad Medical and C4 Imaging announced a partnership to introduce the first positive signal LDR MRI marker that serves as both a seed spacer and a marker. This represents a next step in advancing Brachytherapy for prostate cancer treatment in the United States. The partnership combines Myriad Medical's expertise in prostate immobilization with C4 Imaging's MRI marker technology.

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Market position

Weaknesses5 records

Competitive moat5 records

Customer concentration

• Facebookfacebook.com/MyriadMedical
• LinkedInlinkedin.com/company/myriad-medical-llc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MYRIAD MEDICAL